Impact of COVID-19 in Immunosuppressed Children With Neuroimmunologic Disorders

Background and Objectives To investigate whether children receiving immunosuppressive therapies for neuroimmunologic disorders had (1) increased susceptibility to SARS-CoV2 infection or to develop more severe forms of COVID-19; (2) increased relapses or autoimmune complications if infected; and (3) changes in health care delivery during the pandemic. Methods Patients with and without immunosuppressive treatment were recruited to participate in a...